Sentinel Diagnostics launches the new SENTiFIT®800, a new completely automated and high-throughput instrument for fecal tests

16/06/202218/06/2022

We are glad to announce the launch of new SENTiFIT®800, the first completely automated, high-throughput instrument for fecal tests. SENTiFIT®800 is particularly suitable for FIT screening programs and laboratories that process high volume of samples. It allows to: Satisfy high-throughput needs Reduce the operator hands-on time Increase the laboratory efficiency SENTiFIT®800 joins the range of […]

ECCMID 2022, Lisbon – In-Booth Demonstrations

21/04/202221/04/2022

Sentinel Diagnostics is at the 32nd ECCMID in Lisbon, Portugal. Come to join us at Booth 1-33.1 – On Sunday and Monday, visiting our stand, you would attend in-booth demonstrations about our: SENTiNAT® 200, the integrated system sample to result and SENTiNAT® X48, the automatic nucleic acids extraction and PCR setup system. To book your reservation: marketing@sentinel.it […]

Sentinel Diagnostics at EuroMedLab Congress in Munich, Booth #205

06/04/202207/04/2022

After the postponement of EuroMedLab back in November 2021, we are happy to be present at EuroMedLab in Munich, Germany, on April 10th to 14th. Visiting us in Booth #205, Hall C1 you can: Learn more about our latest molecular diagnostic solutions and see how SENTiNAT®200, our new true sample-to-results system, can improve the laboratory […]

Sentinel Diagnostics is partner in the ColoFuture clinical study with Mainz Biomed and Alcedis GmbH

20/03/202221/03/2022

Sentinel Diagnostics is honored to announce its partnership with Mainz Biomed to support the ColoFuture clinical study, which evaluates the potential to integrate new mRNA biomarkers into ColoAlert, a detector for colorectal cancer (CRC). ColoAlert is a simple-to-administer test with a sensitivity and specificity nearly as high as the invasive colonoscopy. ColoFuture is an international […]

March is the National Colorectal Cancer Awareness Month

16/03/202216/03/2022

Colorectal cancer (CRC) is the third most common cancer in men and women and has the second highest mortality rate worldwide. Several CRC cases are early identified thanks to the numerous screening programs in many countries but also many cases are found in patients presenting with symptoms in primary health care. The laboratory tests for […]

Report 2020 – CRC Screening Program in the Netherlands

04/02/202204/02/2022

Sentinel Diagnostics is supporting World Cancer Day with a Screening Program. World Cancer Day is a global event to raise awareness for prevention in order to diagnose cancer at its early stage and, as a diagnostics company, we know our role is crucial in guaranteeing fast and smart results. For this reason, we would like […]

EcoVadis Certification for Sentinel Diagnostics

01/02/202201/02/2022

The demand of medium-large companies to use the EcoVadis methodology is increasing. This instrument certifies their sustainability standards at an international level (Global Reporting Initiative, United Nations Global Compact, ISO 26000). The supervisor is a scientific committee of RSI and supplies chain experts, who ensure impartial and reliable assessments. In 2021, Sentinel Diagnostics joined and […]

“Top 10 IVD Solution Companies in Europe – 2021”

19/01/202219/01/2022

Sentinel Diagnostics was chosen to be on the cover of the Magazine MD Tech Review for the Special “In Vitro Diagnostics”, Europe Edition. We are honored to be in the “Top 10 In Vitro Diagnostic Solution Companies in Europe – 2021” To help companies navigate through the best-of-breed in vitro diagnostic solution providers, @MD Tech […]

How Many Covids?

15/12/202115/12/2021

An overview of variants and mutations to give us an update on the SARS-CoV-2 VOC* and VOI** as classified by WHO. How often does SARS-CoV-2 mutate? As any virus, it is likely to change or mutate to adapt to the environmental pressure as it infects people. There are several variants that are now spreading, some proving […]

Sentinel Diagnostics’ kits developed for SARS-CoV-2 detection are not affected by Omicron (B.1.1.529) variants

06/12/202106/12/2021

Since the beginning of the COVID-19 pandemic, Sentinel Diagnostics has been working constantly to provide high-quality diagnostic tests, based on patented STAT-NAT® technology, for the detection of SARS-CoV-2 virus. We are constantly monitoring the effectiveness of our NAT tests for the detection of COVID-19 by verifying that variant-defining mutant loci do not fall within primers/probes […]